Exploration of Prognostic Biomarkers of Muscle-Invasive Bladder Cancer (MIBC) by Bioinformatics

por Xu, Xianglai, Wang, Yelin, Zhang, Sihong, Zhu, Yanjun, Wang, Jiajun
Publicado 2021

HMOX1 pathway signature predicts clinical benefit from immunotherapy plus tyrosine kinase inhibitor therapy in advanced renal cell carcinoma

por Xu, Xianglai, Zhang, Sihong, Wang, Ying, Zhu, Yanjun, Wang, Jiajun, Guo, Jianming
Publicado 2023

Effects of PYCR1 on prognosis and immunotherapy plus tyrosine kinase inhibition responsiveness in metastatic renal cell carcinoma patients

por Xu, Xianglai, Wang, Ying, Hu, Xinyu, Zhu, Yanjun, Wang, Jiajun, Guo, Jianming
Publicado 2023

Favorable Immunotherapy Plus Tyrosine Kinase Inhibition Outcome of Renal Cell Carcinoma Patients with Low CDK5 Expression

por Xu, Xianglai, Wang, Ying, Chen, Zhaoyi, Zhu, Yanjun, Wang, Jiajun, Guo, Jianming
Publicado 2023

Recent Progress in Vascular Aging: Mechanisms and Its Role in Age-related Diseases

por Xu, Xianglai, Wang, Brian, Ren, Changhong, Hu, Jiangnan, Greenberg, David A., Chen, Tianxiang, Xie, Liping, Jin, Kunlin
Publicado 2017

Age-related Impairment of Vascular Structure and Functions

por Xu, Xianglai, Wang, Brian, Ren, Changhong, Hu, Jiangnan, Greenberg, David A., Chen, Tianxiang, Xie, Liping, Jin, Kunlin
Publicado 2017

Quantitative assessment of the associations between XRCC1 polymorphisms and bladder cancer risk

por Mao, Yeqing, Xu, Xin, Lin, Yiwei, Chen, Hong, Wu, Jian, Hu, Zhenghui, Zhu, Yi, Xu, Xianglai, Xie, Liping
Publicado 2013

Apigenin promotes apoptosis, inhibits invasion and induces cell cycle arrest of T24 human bladder cancer cells

por Zhu, Yi, Mao, Yeqing, Chen, Hong, Lin, Yiwei, Hu, Zhenghui, Wu, Jian, Xu, Xin, Xu, Xianglai, Qin, Jie, Xie, Liping
Publicado 2013

Diabetes Mellitus and Risk of Bladder Cancer: A Meta-Analysis of Cohort Studies

por Xu, Xin, Wu, Jian, Mao, Yeqing, Zhu, Yi, Hu, Zhenghui, Xu, Xianglai, Lin, Yiwei, Chen, Hong, Zheng, Xiangyi, Qin, Jie, Xie, Liping
Publicado 2013

MicroRNA-320c inhibits tumorous behaviors of bladder cancer by targeting Cyclin-dependent kinase 6

por Wang, Xiao, Wu, Jian, Lin, Yiwei, Zhu, Yi, Xu, Xianglai, Xu, Xin, Liang, Zhen, Li, Shiqi, Hu, Zhenghui, Zheng, Xiangyi, Xie, Liping
Publicado 2014

PAI-1 promoter 4G/5G polymorphism (rs1799768) contributes to tumor susceptibility: Evidence from meta-analysis

por XU, XIN, XIE, YANQI, LIN, YIWEI, XU, XIANGLAI, ZHU, YI, MAO, YEQING, HU, ZHENGHUI, WU, JIAN, CHEN, HONG, ZHENG, XIANGYI, QIN, JIE, XIE, LIPING
Publicado 2012

MicroRNA-124-3p inhibits cell migration and invasion in bladder cancer cells by targeting ROCK1

por Xu, Xianglai, Li, Shiqi, Lin, Yiwei, Chen, Hong, Hu, Zhenghui, Mao, Yeqing, Xu, Xin, Wu, Jian, Zhu, Yi, Zheng, Xiangyi, Luo, Jindan, Xie, Liping
Publicado 2013

Downregulation of microRNA-182-5p contributes to renal cell carcinoma proliferation via activating the AKT/FOXO3a signaling pathway

por Xu, Xin, Wu, Jian, Li, Shiqi, Hu, Zhenghui, Xu, Xianglai, Zhu, Yi, Liang, Zhen, Wang, Xiao, Lin, Yiwei, Mao, Yeqing, Chen, Hong, Luo, Jindan, Liu, Ben, Zheng, Xiangyi, Xie, Liping
Publicado 2014

MicroRNA-193a-3p inhibits cell proliferation in prostate cancer by targeting cyclin D1

por Liu, Yunfu, Xu, Xin, Xu, Xianglai, Li, Shiqi, Liang, Zhen, Hu, Zhenghui, Wu, Jian, Zhu, Yi, Jin, Xiaodong, Wang, Xiao, Lin, Yiwei, Chen, Hong, Mao, Yeqing, Luo, Jindan, Zheng, Xiangyi, Xie, Liping
Publicado 2017

Up-regulation of p16 by miR-877-3p inhibits proliferation of bladder cancer

por Li, Shiqi, Zhu, Yi, Liang, Zhen, Wang, Xiao, Meng, Shuai, Xu, Xin, Xu, Xianglai, Wu, Jian, Ji, Alin, Hu, Zhenghui, Lin, Yiwei, Chen, Hong, Mao, Yeqing, Wang, Wei, Zheng, Xiangyi, Liu, Ben, Xie, Liping
Publicado 2016

Correction: Up-regulation of p16 by miR-877-3p inhibits proliferation of bladder cancer

por Li, Shiqi, Zhu, Yi, Liang, Zhen, Wang, Xiao, Meng, Shuai, Xu, Xin, Xu, Xianglai, Wu, Jian, Ji, Alin, Hu, Zhenghui, Lin, Yiwei, Chen, Hong, Mao, Yeqing, Wang, Wei, Zheng, Xiangyi, Liu, Ben, Xie, Liping
Publicado 2019